Pharmacodynamics of basic fibroblast growth factor: Route of administration determines myocardial and systemic distribution

Cardiovascular Research

Volumn 36, Issue 1, 1997, Pages 78-85

  Lazarous, Daisy F ^a   Shou, Matie ^a   Stiber, Jonathan A ^a   Dadhania, Darshana M ^a   Thirumurti, Venugopal ^a   Hodge, Everett ^a   Unger, Ellis F ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Angiogenesis; bFGF; Dog; Growth factors; Myocardium; Pharmacodynamics

Indexed keywords

IODINE 125; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; DRUG UPTAKE; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; INTRACARDIAC DRUG ADMINISTRATION; INTRACORONARY INFUSION; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RADIOIODINATION; TISSUE DISTRIBUTION;

ANIMALS; CATHETERIZATION, SWAN-GANZ; COLLATERAL CIRCULATION; CORONARY CIRCULATION; DOGS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST GROWTH FACTOR 2; HALF-LIFE; HEART ATRIA; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; IODINE RADIOISOTOPES; KIDNEY; LIVER; LUNG; MALE; MYOCARDIUM; PERICARDIUM; PULMONARY ARTERY; SPLEEN;

EID: 0030721619     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00142-9     Document Type: Article

References (32)

1. Lazarous DF, Scheinowitz M, Shou M, et al. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 1995; 91:145-153.
2. Lazarous DF, Shou M, Scheinowitz M. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 1996; 94:1074-1082.
3. Unger EF, Banai S, Shou M. et al. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 1994; 266:H1588-H1595.
4. Rajanayagam S, Shou M, Thirumurti V, et al. Two intracoronary doses of basic fibroblast growth factor enhance collateral blood flow in dogs. J Am Coll Cardiol 1996; 27 (Suppl A): 36A. Abstract.
5. Whalen GF, Shing Y, Folkman J. The fate of intravenously administered bFGF and the effect of heparin. Growth Factors 1989; 1:157-164.
6. Edelman ER, Nugent MA, Karnovsky MJ. Perivascular and intravenous administration of basic fibroblast growth factor: Vascular and solid organ deposition. Proc Natl Acad Sci USA 1993; 90:1513-1517.
7. Bolton AE, Hunter WM, Biochem 1973; 133: 529-539.
8. Marin F, Boya J. Immunocytochemical localization of basic fibroblast growth factor in the human pituitary gland. Neuroendocrinol 1995; 62:523-529.
9. Hughes SE, Hall PA. Immunolocalization of fibroblast growth factor receptor 1 and its ligands in human tissues. Lab Invest 1993; 69:173-182.
10. Cauchi J, Alcorn D, Cancilla B, et al. Light microscopic immunolocalization of fibroblast growth factor-1 and -2 in adult rat kidney. Cell Tissue Res 1996; 285:179-187.
11. Yanagisawa-Miwa A, Uchida Y, Nakamura F, et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992; 257:1401-1403.
12. Chleboun JO, Martins RN, Mitchell CA, Chirila TV. bFGF enhances the development of the collateral circulation after acute arterial occlusion. Biochem Biophys Res Commun 1992; 185:510-516.
13. Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose response effect of basic fibroblast growth factor. J Vasc Surg 1992; 16:181-191.
14. Battler A, Scheinowitz M, Bor A, et al. Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium. J Am Coll Cardiol 1993; 22:2001-2006.
15. Harada KH, Grossman W, Friedman M. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest 1994; 94:623-630.
16. Asahara T, Bauters C, Zheng LP, et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 1995; 92 (suppl II) 365-371.
17. Bashkin P, Doctrow S, Klagsbrun M. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 1989; 28:1737-1743.
18. Folkman J, Klagsbrun M, Sasse J. A heparin-binding angiogenic protein - basic fibroblast growth factor - is stored within basement membrane. Am J Path 1988; 130:393-400.
19. Flaumenhaft R, Moscatelli D, Saksela O, Rifkin DB. Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis. J Cell Physiol 1989; 140:75-81.
20. Cohen MV, Vernon J, Yaghdjian V, Hatcher VB. Longitudinal changes in myocardial basic fibroblast growth factor (FGF-2) activity following coronary artery ligation in the dog. J Mol Cell Cardiol 1994; 26:683-690.
21. Dupuis J, Stewart DJ, Cernacek P, Gosselin G. Human pulmonary circulation is an important site for clearance and production of Endothelin-1. Circulation 1996; 94:1578-1584.
22. Yang HT, Deschenes MR, Ogilvie RW, Terjung RL. Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. Circ Res 1996; 79:62-69.
23. Fisher M, Meadows ME, Do T. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1995; 15:953-959.
24. Jiang N, Finklestein SP, Do T, et al. Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the rat. J Neurol Sci 1996; 139:173-179.
25. Bethel A, Kirsch J, Koehler RC, Finklestein, SP, et al. Intravenous basic fibroblast growth factor decreases brain injury resulting from focal ischemia in cats. Stroke 1996. In press.
26. Landau C, Jacobs AK, Haudenschild CC. Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia. Am Heart J 1995; 129:924-931.
27. Uchida Y, Yanagisawa-Miwa A, Nakamura F, et al. Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: An experimental study. Am Heart J 1995; 130:1182-1188.
28. Arakawa T, Wen J, Philo JS. Stoichiometry of heparin binding to basic fibroblast growth factor. Arch Biochem Biophys 1994; 308:267-273.
29. Roghani M, Mansukhani A, Dell'Era P, et al. Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J Biol Chem 1994; 269:3976-3984.
30. Aviezer D, Levy E, Safran M, et al. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J Biol Chem 1994; 269:114-121.
31. Cauchi J, Alcorn D, Cancilla B, et al. Light microscopic immunolocalization of fibroblast growth factor-1 and -2 in adult rat kidney. Cell Tissue Res 1996; 285:179-187.
32. Mazué G, Newman AJ, Scampini G. The histopathology of kidney changes in rats and monkeys following intravenous administration of massive doses of FCE 26184, human basic fibroblast growth factor. Toxicol Pathol 1993; 21:490-501.